Efficacy of a thumb opponens splint on manual dexterity in patients with Hereditary Motor and Sensory Neuropathy: a pilot study

Efficacy of a thumb opponens splint on manual dexterity in patients with Hereditary Motor and Sensory Neuropathy: a pilot study - Thumb opponens splint in HMSN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32255

Enrollment

Registered

2008-04-17

Start date

2008-02-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Charcot-Marie-Tooth disease Hereditary Motor and Sensory Neuropathy

Interventions

The intervention consists of a custom made short thumb opponens splint for the dominant hand. Patients will wear the splint during 6 weeks.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosis of HMSN confirmed by DNA or electrophysiological study; Age between 18 and 70 years; Loss of opposition (kapandji score

Exclusion criteria

Exclusion criteria: Other disabling disorders in the medical history that might influence hand function of the dominant hand; Difficulty comprehending the Dutch language;

Design outcomes

Primary

Measure	Time frame
Manual dexterity assessed with the Sollerman hand function test. The Sollerman test consists of 20 unilateral and bilateral subtests, each comprising a task considered to be an activity of daily living. The tasks reflect the most common handgrips used in daily life. The time necessary to perform the task and the quality of movement of the hand are recorded (test administration time 30-60 min).	—

Secondary

Measure	Time frame
Manual dexterity assessed with the Functional Dexterity test (FDT). The FDT provides information regarding the patient's ability to use the hand for functional daily tasks that require a 3-jaw-chuck prehension between the fingers and the thumb. An advantage of this test is that it requires a minimum amount of time for administration (15 seconds to 2 minutes). Perceived physical functioning of the upper extremity, assessed using the Dutch language version of the Michigan Hand Outcomes Questionnaire (MHOQ-DLV). The MHOQ is a self-administered questionnaire. The mean time required to complete the questionnaire is 10 minutes. Occupational performance assessed with the Canadian Occupational Performance Measure (COPM). The COPM is a measure of a clients self-perception of occupational performance in the areas of self-care, productivity and leisure. Outcome measures of the COPM are: clients most important problems in occupational performance and a total score for performance and a total score for satisfaction for these problems. Perceived usability of the splint will be assessed with a questionnaire specifically designed for the purpose of the study.	—

Measure

Time frame

Manual dexterity assessed with the Functional Dexterity test (FDT). The FDT provides information regarding the patient's ability to use the hand for functional daily tasks that require a 3-jaw-chuck prehension between the fingers and the thumb. An advantage of this test is that it requires a minimum amount of time for administration (15 seconds to 2 minutes). Perceived physical functioning of the upper extremity, assessed using the Dutch language version of the Michigan Hand Outcomes Questionnaire (MHOQ-DLV). The MHOQ is a self-administered questionnaire. The mean time required to complete the questionnaire is 10 minutes. Occupational performance assessed with the Canadian Occupational Performance Measure (COPM). The COPM is a measure of a client*s self-perception of occupational performance in the areas of self-care, productivity and leisure. Outcome measures of the COPM are: client*s most important problems in occupational performance and a total score for performance and a total score for satisfaction for these problems. Perceived usability of the splint will be assessed with a questionnaire specifically designed for the purpose of the study.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)